Blue Cross Blue Shield of Michigan Postpones Modifier 25 Policy in Response to Osteopathic Advocacy

Key Takeaways

• BCBSM delays Michigan modifier 25 reimbursement rule.
• Five osteopathic groups led advocacy for the postponement.
• Delay protects accurate billing for osteopathic manipulative treatment.
• Reduces administrative burden for Michigan physicians.
• Sets precedent for provider‑driven policy input.

Pulse Analysis

Modifier 25 is a critical billing code that signals a distinct, separately reimbursable service performed on the same day as an evaluation and management visit. Insurers sometimes adjust its application to curb perceived overuse, but such changes can unintentionally penalize providers who deliver essential services like osteopathic manipulative treatment (OMT). In Michigan, Blue Cross Blue Shield’s draft policy threatened to limit reimbursement for OMT when paired with other services, raising concerns about revenue integrity and patient access to comprehensive care.

The pushback came from a coalition of osteopathic leaders—including the Michigan Osteopathic Association, the American Osteopathic Association, and specialty societies such as the American College of Osteopathic Family Physicians. Their unified message emphasized that modifier 25 safeguards accurate capture of OMT, a service uniquely tied to the osteopathic model of patient‑centered care. By securing a postponement, the groups not only protected current billing practices but also bought time for a more data‑driven review, reducing administrative headaches for physicians and preserving the financial viability of osteopathic practices.

Beyond Michigan, the episode underscores a growing trend: payers are increasingly responsive to organized clinician advocacy when policy proposals threaten clinical workflows. It highlights the importance of proactive engagement by professional societies to shape reimbursement frameworks that reflect real‑world practice. As insurers continue to refine coding guidelines, the osteopathic community’s success may serve as a blueprint for other specialties seeking to influence payer decisions and ensure that payment models support high‑quality, patient‑focused care.